Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
AI In Bioinformatics Market Forecast: Value Set To Climb From $8.81 Billion To $37.63 Billion
The ai in bioinformatics market size has seen rapid expansion in recent years. This market is expected to increase from $6.14 billion in 2025 to $8.81 billion in 2026, showing a compound annual growth rate (CAGR) of 43.6%. In previous periods, this growth was fueled by factors such as the expanding volume of genomic data, the increased uptake of next-generation sequencing, a rise in bioinformatics research funding, the initial integration of machine learning in life sciences, and the development of public biological databases.
The ai in bioinformatics market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $37.63 billion by 2030, demonstrating a robust compound annual growth rate (CAGR) of 43.7%. This growth during the forecast period is propelled by factors such as the increasing demand for precision medicine, the growing adoption of AI in clinical decision support, rising pharmaceutical R&D investments, advancements in deep learning architectures, and the escalating need for accelerated drug development cycles. Prominent trends for the upcoming period include AI-driven genomic data interpretation, automated drug discovery and target identification, the integration of multi-omics data platforms, cloud-based bioinformatics workflows, and advanced predictive modeling for protein structures.
Get A Free Sample Report With In-Depth Market Insights:
AI In Bioinformatics Market Expansion Drivers: What’s Shaping Future Growth?
The rising volume of clinical trials is anticipated to drive the expansion of AI within the bioinformatics market moving ahead. These trials represent a structured and meticulously planned medical research approach, involving human participants to assess the safety, effectiveness, and overall impact of novel medical interventions, therapies, medications, devices, or strategies. Within clinical trials, AI in bioinformatics facilitates the analysis of patient data from electronic health records and various other sources to identify suitable candidates who fulfill particular criteria, thereby enhancing recruitment precision and effectiveness. As an illustration, figures from May 2023 reported by Xtalks, a Canada-based life science and medical device platform, indicated that ClinicalTrials.gov had 452,604 clinical trials registered globally by May 2023, with 64,838 of these actively recruiting participants. This number signifies a substantial increase from over 365,000 registered trials noted at the start of 2021. Consequently, the escalating number of clinical trials is a primary factor fueling the advancement of AI in the bioinformatics market.
AI In Bioinformatics Market Segment Analysis And Revenue Potential
The ai in bioinformatics market covered in this report is segmented –
1) By Type: Machine Learning, Deep Learning, Other Types
2) By Offering: Services, Software
3) By Application: Genomics, Chemoinformatics And Drug Design, Proteomics, DNA Sequencing, System Biology, Transcriptomics, Microarrays, Metabolomics, Other Applications
Subsegments:
1) By Machine Learning: Supervised Learning Algorithms, Unsupervised Learning Algorithms
2) By Deep Learning: Neural Networks, Natural Language Processing Models
3) By Other Types: Statistical Models, Evolutionary Algorithms
AI In Bioinformatics Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies operating within the AI in bioinformatics market are developing technological advancements on the Bionl.AI platform to enhance their market profitability. Bionl.AI offers a complete workspace for exploration, analysis, and visualization, drastically shortening the time needed to finish complex tasks from several days to mere minutes. For instance, in October 2023, Bionl Inc., a US-based biomedical and bioinformatics research platform company, unveiled Bionl.AI. This pioneering platform aims to revolutionize biomedical and bioinformatics research by providing a no-code solution for researchers, students, and professionals to investigate biomedicine using natural language queries. The platform leverages state-of-the-art GenAI models to enable immediate insights and render complex analysis both accessible and engaging.
AI In Bioinformatics Market Key Players Shaping Industry Direction
Major companies operating in the ai in bioinformatics market are Dassault Systèmes SE, QIAGEN N.V., SomaLogic Operating Co. Inc., Seven Bridges Genomics Inc., Genialis Inc., SOPHiA GENETICS SA, DNAnexus Inc., Insilico Medicine Inc., Deep Genomics Inc., Biomax Informatics Inc., Ardigen SA, Strand Life Sciences Pvt. Ltd., Genomenon Inc., Fios Genomics Limited, BlueBee Holding BV, JADBio, Elucidata Corporation, Gnosis DA, DNASTAR Inc., iNDX.Ai, Paige AI Inc.
View The Full AI In Bioinformatics Market Report:
AI In Bioinformatics Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the AI in bioinformatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ai in bioinformatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
